PRISMAFLEX TPE 2000 SET - The Prismaflex TPE2000 set is indicated for use - GAMBRO INDUSTRIES

Duns Number:393020474

Device Description: The Prismaflex TPE2000 set is indicated for use only with the PrismaFlex control unit or w The Prismaflex TPE2000 set is indicated for use only with the PrismaFlex control unit or with the PrisMax control unit (in countries where PrisMax is cleared or registered), after having selected TPE therapy. The Prismaflex TPE2000 set is intended for use in therapeutic plasma exchange, thus in diseases where removal of plasma components in indicated.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

114093

Brand Name

PRISMAFLEX TPE 2000 SET

Version/Model Number

114093

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

Yes

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

P830063,P830063,P830063,P830063

Product Code Details

Product Code

MDP

Product Code Name

Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma

Device Record Status

Public Device Record Key

214a1eb8-bc63-46c4-b586-c4d704367679

Public Version Date

October 11, 2022

Public Version Number

7

DI Record Publish Date

March 23, 2017

Additional Identifiers

Package DI Number

37332414111039

Quantity per Package

4

Contains DI Package

07332414111038

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

CASE

"GAMBRO INDUSTRIES" Characteristics
Device Class Device Class Description No of Devices
2 A medical device with a moderate to high risk that requires special controls. 6